Atlas Trials

Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS

Clinical trial NCT03660228 · COMPLETED

Trial details

NCT number
NCT03660228
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2018-10-17
Primary completion
2021-06-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.